Global and United States Dermatology Drug In-Depth Research Report 2017-2022

Published: Aug, 2017 | Pages: 117 | Publisher: US Market Insight (UMI)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Dermatology Drug industry.

Major Companies
    AbbVie (U.S.)
    Johnson & Johnson (U.S.)
    Bayer (Germany)
    Galderma (Switzerland)
    Bristol-Myers Squibb (U.S.)
    Novartis (China)
    Pfizer (U.S.)
    Merz Pharma (Germany)
    Valeant (Canada)
    LEO Pharma (Denmark)
    GlaxoSmithKline (UK)

Key Regions
    North America
        United States
            California
            Texas
            New York
            Others
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
Dermatology Drug Market, by Route of Administration
    External Use
    Oral
    Injection
Dermatology Drug Market, by Form
    Ointment
    Liquid
    Powder
    Spray

Dermatology Drug Market, by Key Consumers
    Psoriasis
    Skin Infections
    Acne
    Dermatitis
    Other

 Table of Contents

Global and United States Dermatology Drug In-Depth Research Report 2017-2022
Chapter One Global Dermatology Drug Market Overview
    1.1 Global Dermatology Drug Market Sales Volume Revenue and Price 2012-2017
    1.2 Dermatology Drug, by Route of Administration 2012-2017
        1.2.1 Global Dermatology Drug Sales Market Share by Route of Administration 2012-2017
        1.2.2 Global Dermatology Drug Revenue Market Share by Route of Administration 2012-2017
        1.2.3 Global Dermatology Drug Price by Route of Administration 2012-2017
        1.2.4 External Use
        1.2.5 Oral
        1.2.6 Injection
    1.3 Dermatology Drug, by Form 2012-2017
        1.3.1 Global Dermatology Drug Sales Market Share by Form 2012-2017
        1.3.2 Global Dermatology Drug Revenue Market Share by Form 2012-2017
        1.3.3 Global Dermatology Drug Price by Form 2012-2017
        1.3.4 Ointment
        1.3.5 Liquid
        1.3.6 Powder
        1.3.7 Spray

Chapter Two United States Dermatology Drug Market Overview
    2.1 United States Dermatology Drug Market Sales Volume Revenue and Price 2012-2017
    2.2 Dermatology Drug, by Route of Administration 2012-2017
        2.2.1 United States Dermatology Drug Sales Market Share by Route of Administration 2012-2017
        2.2.2 United States Dermatology Drug Revenue Market Share by Route of Administration 2012-2017
        2.2.3 United States Dermatology Drug Price by Route of Administration 2012-2017
        2.2.4 External Use
        2.2.5 Oral
        2.2.6 Injection
    2.3 Dermatology Drug, by Form 2012-2017
        2.3.1 United States Dermatology Drug Sales Market Share by Form 2012-2017
        2.3.2 United States Dermatology Drug Revenue Market Share by Form 2012-2017
        2.3.3 United States Dermatology Drug Price by Form 2012-2017
        2.3.4 Ointment
        2.3.5 Liquid
        2.3.6 Powder
        2.3.7 Spray

Chapter Three Dermatology Drug by Regions 2012-2017
    3.1 Global Dermatology Drug Sales Market Share by Regions 2012-2017
    3.2 Global Dermatology Drug Revenue Market Share by Regions 2012-2017
    3.3 Global Dermatology Drug Price by Regions 2012-2017
    3.4 North America
        3.4.1 United States
            3.4.1.1 California
            3.4.1.2 Texas
            3.4.1.3 New York
            3.4.1.4 Others in United States
        3.4.2 Canada
    3.5 Latin America
        3.5.1 Mexico
        3.5.2 Brazil
        3.5.3 Argentina
        3.5.4 Others in Latin America
    3.6 Europe
        3.6.1 Germany
        3.6.2 United Kingdom
        3.6.3 France
        3.6.4 Italy
        3.6.5 Spain
        3.6.6 Russia
        3.6.7 Netherland
        3.6.8 Others in Europe
    3.7 Asia & Pacific
        3.7.1 China
        3.7.2 Japan
        3.7.3 India
        3.7.4 Korea
        3.7.5 Australia
        3.7.6 Southeast Asia
            3.7.6.1 Indonesia
            3.7.6.2 Thailand
            3.7.6.3 Philippines
            3.7.6.4 Vietnam
            3.7.6.5 Singapore
            3.7.6.6 Malaysia
            3.7.6.7 Others in Southeast Asia
    3.8 Africa & Middle East
        3.8.1 South Africa
        3.8.2 Egypt
        3.8.3 Turkey
        3.8.4 Saudi Arabia
        3.8.5 Iran
        3.8.6 Others in Africa & Middle East

Chapter Four Global Dermatology Drug by Companies 2012-2017
    4.1 Global Dermatology Drug Sales Volume Market Share by Companies 2012-2017
    4.2 Global Dermatology Drug Revenue Share by Companies 2012-2017
    4.3 Global Top Companies Dermatology Drug Key Product Model and Market Performance
    4.4 Global Top Companies Dermatology Drug Key Target Consumers and Market Performance

Chapter Five United States Dermatology Drug by Companies 2012-2017
    5.1 United States Dermatology Drug Sales Volume Market Share by Companies 2012-2017
    5.2 United States Dermatology Drug Revenue Share by Companies 2012-2017
    5.3 United States Top Companies Dermatology Drug Key Product Model and Market Performance
    5.4 United States Top Companies Dermatology Drug Key Target Consumers and Market Performance

Chapter Six Global Dermatology Drug by Consumer 2012-2017
    6.1 Global Dermatology Drug Sales Market Share by Consumer 2012-2017
    6.2 Psoriasis
    6.3 Skin Infections
    6.4 Acne
    6.5 Dermatitis
    6.6 Other
    6.7 Consuming Habit and Preference

Chapter Seven Global Dermatology Drug by Consumer 2012-2017
    7.1 Global Dermatology Drug Sales Market Share by Consumer 2012-2017
    7.2 Psoriasis
    7.3 Skin Infections
    7.4 Acne
    7.5 Dermatitis
    7.6 Other
    7.7 Consuming Habit and Preference

Chapter Eight Top Companies Profile
    8.1 AbbVie (U.S.)
        8.1.1 AbbVie (U.S.) Company Details and Competitors
        8.1.2 AbbVie (U.S.) Key Dermatology Drug Models and Performance
        8.1.3 AbbVie (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
        8.1.4 AbbVie (U.S.) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    8.2 Johnson & Johnson (U.S.)
        8.2.1 Johnson & Johnson (U.S.) Company Details and Competitors
        8.2.2 Johnson & Johnson (U.S.) Key Dermatology Drug Models and Performance
        8.2.3 Johnson & Johnson (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
        8.2.4 Johnson & Johnson (U.S.) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    8.3 Bayer (Germany)
        8.3.1 Bayer (Germany) Company Details and Competitors
        8.3.2 Bayer (Germany) Key Dermatology Drug Models and Performance
        8.3.3 Bayer (Germany) Dermatology Drug Business SWOT Analysis and Forecast
        8.3.4 Bayer (Germany) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    8.4 Galderma (Switzerland)
        8.4.1 Galderma (Switzerland) Company Details and Competitors
        8.4.2 Galderma (Switzerland) Key Dermatology Drug Models and Performance
        8.4.3 Galderma (Switzerland) Dermatology Drug Business SWOT Analysis and Forecast
        8.4.4 Galderma (Switzerland) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    8.5 Bristol-Myers Squibb (U.S.)
        8.5.1 Bristol-Myers Squibb (U.S.) Company Details and Competitors
        8.5.2 Bristol-Myers Squibb (U.S.) Key Dermatology Drug Models and Performance
        8.5.3 Bristol-Myers Squibb (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
        8.5.4 Bristol-Myers Squibb (U.S.) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    8.6 Novartis (China)
        8.6.1 Novartis (China) Company Details and Competitors
        8.6.2 Novartis (China) Key Dermatology Drug Models and Performance
        8.6.3 Novartis (China) Dermatology Drug Business SWOT Analysis and Forecast
        8.6.4 Novartis (China) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    8.7 Pfizer (U.S.)
        8.7.1 Pfizer (U.S.) Company Details and Competitors
        8.7.2 Pfizer (U.S.) Key Dermatology Drug Models and Performance
        8.7.3 Pfizer (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
        8.7.4 Pfizer (U.S.) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    8.8 Merz Pharma (Germany)
        8.8.1 Merz Pharma (Germany) Company Details and Competitors
        8.8.2 Merz Pharma (Germany) Key Dermatology Drug Models and Performance
        8.8.3 Merz Pharma (Germany) Dermatology Drug Business SWOT Analysis and Forecast
        8.8.4 Merz Pharma (Germany) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    8.9 Valeant (Canada)
        8.9.1 Valeant (Canada) Company Details and Competitors
        8.9.2 Valeant (Canada) Key Dermatology Drug Models and Performance
        8.9.3 Valeant (Canada) Dermatology Drug Business SWOT Analysis and Forecast
        8.9.4 Valeant (Canada) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    8.10 LEO Pharma (Denmark)
        8.10.1 LEO Pharma (Denmark) Company Details and Competitors
        8.10.2 LEO Pharma (Denmark) Key Dermatology Drug Models and Performance
        8.10.3 LEO Pharma (Denmark) Dermatology Drug Business SWOT Analysis and Forecast
        8.10.4 LEO Pharma (Denmark) Dermatology Drug Sales Volume Revenue Price Cost and Gross Margin
    8.11 GlaxoSmithKline (UK)

Chapter Nine Industry Chain and Supply Chain
    9.1 Dermatology Drug Industry Chain Structure
        9.1.1 R&D
        9.1.2 Raw Materials (Components)
        9.1.3 Manufacturing Plants
        9.1.4 Regional Trading (Import Export and Local Sales)
        9.1.5 Online Sales Channel
        9.1.6 Offline Channel
        9.1.7 End Users
    9.2 Dermatology Drug Manufacturing
        9.2.1 Key Components
        9.2.2 Assembly Manufacturing
    9.3 Consumer Preference
    9.4 Behavioral Habits
    9.5 Marketing Environment

Chapter Ten Global Dermatology Drug Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Dermatology Drug Sales (K MT), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Dermatology Drug Sales (K MT) Forecast by Regions (2017-2022)
    10.3 Global Dermatology Drug Sales (K MT) Forecast by Application (2017-2022)
    10.4 Global Dermatology Drug Sales (K MT) Forecast by Route of Administration (2017-2022)
    10.5 Global Dermatology Drug Sales (K MT) Forecast by Form (2017-2022)

Chapter Eleven United States Dermatology Drug Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 United States Dermatology Drug Sales (K MT), Revenue (Million USD) Forecast (2017-2022)
    11.2 United States Dermatology Drug Sales (K MT) Forecast by Regions (2017-2022)
    11.3 United States Dermatology Drug Sales (K MT) Forecast by Application (2017-2022)
    11.4 United States Dermatology Drug Sales (K MT) Forecast by Route of Administration (2017-2022)
    11.5 United States Dermatology Drug Sales (K MT) Forecast by Form (2017-2022)

Chapter Twelve Development Trend and Research Conclusion
    12.1 Development Trend
    12.2 Research Conclusion

Chapter Thirteen Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Table Global Dermatology Drug Sales Volume (K MT), Revenue (Million USD) and Price (USD/MT)(2012-2017)
    Figure Global Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Dermatology Drug Sales Volume (K MT) and Growth Rate (2012-2017)
    Table Global Dermatology Drug Sales (K MT) by Route of Administration (2012-2017)
    Table Global Dermatology Drug Sales Market Share by Route of Administration (2012-2017)
    Figure Global Dermatology Drug Sales Market Share by Route of Administration in 2016
    Table Global Dermatology Drug Revenue (Million USD) by Route of Administration (2012-2017)
    Table Global Dermatology Drug Revenue Market Share by Route of Administration (2012-2017)
    Figure Global Dermatology Drug Revenue Market Share by Route of Administration in 2016
    Table Global Dermatology Drug Price (USD/MT) by Route of Administration (2012-2017)
    Table Top Companies of External Use Dermatology Drug Products List
    Figure Global External Use Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Companies of Oral Dermatology Drug Products List
    Figure Global Oral Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Companies of Injection Dermatology Drug Products List
    Figure Global Injection Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Global Dermatology Drug Sales (K MT) by Form (2012-2017)
    Table Global Dermatology Drug Sales Market Share by Form (2012-2017)
    Figure Global Dermatology Drug Sales Market Share by Form in 2016
    Table Global Dermatology Drug Revenue (Million USD) by Form (2012-2017)
    Table Global Dermatology Drug Revenue Market Share by Form (2012-2017)
    Figure Global Dermatology Drug Revenue Market Share by Form in 2016
    Table Global Dermatology Drug Price (USD/MT) by Form (2012-2017)
    Table Top Companies of Ointment Dermatology Drug Products List
    Figure Global Ointment Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Companies of Liquid Dermatology Drug Products List
    Figure Global Liquid Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Companies of Powder Dermatology Drug Products List
    Figure Global Powder Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Companies of Spray Dermatology Drug Products List
    Figure Global Spray Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Figure United States Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States Dermatology Drug Sales Volume (K MT) and Growth Rate (2012-2017)
    Table United States Dermatology Drug Sales (K MT) by Route of Administration (2012-2017)
    Table United States Dermatology Drug Sales Market Share by Route of Administration (2012-2017)
    Figure United States Dermatology Drug Sales Market Share by Route of Administration in 2016
    Table United States Dermatology Drug Revenue (Million USD) by Route of Administration (2012-2017)
    Table United States Dermatology Drug Revenue Market Share by Route of Administration (2012-2017)
    Figure United States Dermatology Drug Revenue Market Share by Route of Administration in 2016
    Table United States Dermatology Drug Price (USD/MT) by Route of Administration (2012-2017)
    Table Top Companies of External Use Dermatology Drug Products List
    Figure United States External Use Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Companies of Oral Dermatology Drug Products List
    Figure United States Oral Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Companies of Injection Dermatology Drug Products List
    Figure United States Injection Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table United States Dermatology Drug Sales (K MT) by Form (2012-2017)
    Table United States Dermatology Drug Sales Market Share by Form (2012-2017)
    Figure United States Dermatology Drug Sales Market Share by Form in 2016
    Table United States Dermatology Drug Revenue (Million USD) by Form (2012-2017)
    Table United States Dermatology Drug Revenue Market Share by Form (2012-2017)
    Figure United States Dermatology Drug Revenue Market Share by Form in 2016
    Table United States Dermatology Drug Price (USD/MT) by Form (2012-2017)
    Table Top Companies of Ointment Dermatology Drug Products List
    Figure United States Ointment Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Companies of Liquid Dermatology Drug Products List
    Figure United States Liquid Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Companies of Powder Dermatology Drug Products List
    Figure United States Powder Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Top Companies of Spray Dermatology Drug Products List
    Figure United States Spray Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Global Dermatology Drug Sales (K MT) by Regions (2012-2017)
    Table Global Dermatology Drug Sales Share by Regions (2012-2017)
    Figure Global Dermatology Drug Sales Market Share by Regions in 2016
    Figure Global Dermatology Drug Sales Market Share by Regions in 2017
    Table Global Dermatology Drug Revenue (Million USD) and Market Share by Regions (2012-2017)
    Table Global Dermatology Drug Revenue Market Share by Regions (2012-2017)
    Figure Global Dermatology Drug Revenue Market Share by Regions in 2016
    Figure Global Dermatology Drug Revenue Market Share by Regions in 2017
    Table Global Dermatology Drug Price (USD/MT) by Regions (2012-2017)
    Table North America Dermatology Drug Sales (K MT) by Regions (2012-2017)
    Table North America Dermatology Drug Revenue (Million USD) by Regions (2012-2017)
    Figure North America Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table United States Dermatology Drug Sales (K MT) by Regions (2012-2017)
    Table United States Dermatology Drug Revenue (Million USD) by Regions (2012-2017)
    Figure United States Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Latin America Dermatology Drug Sales (K MT) by Regions (2012-2017)
    Table Latin America Dermatology Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Europe Dermatology Drug Sales (K MT) by Regions (2012-2017)
    Table Europe Dermatology Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Asia & Pacific Dermatology Drug Sales (K MT) by Regions (2012-2017)
    Table Asia & Pacific Dermatology Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Africa & Middle East Dermatology Drug Sales (K MT) by Regions (2012-2017)
    Table Africa & Middle East Dermatology Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table Global Dermatology Drug Sales Volume (K MT) by Major Companies (2012-2017)
    Table Global Dermatology Drug Sales Volume Market Share by Major Companies (2012-2017)
    Figure Global Dermatology Drug Sales Volume Market Share by Major Companies 2016
    Figure Global Dermatology Drug Sales Volume Market Share by Major Companies 2017
    Table Global Dermatology Drug Revenue (Million USD) by Major Companies (2012-2017)
    Table Global Dermatology Drug Revenue Market Share by Major Companies (2012-2017)
    Figure Global Dermatology Drug Revenue Market Share by Major Companies 2016
    Figure Global Dermatology Drug Revenue Market Share by Major Companies 2017
    Table Global Top Companies Key Product Model and Market Performance
    Table Global Top Companies Key Target Consumers and Market Performance
    Table United States Dermatology Drug Sales Volume (K MT) by Top Companies (2012-2017)
    Table United States Dermatology Drug Sales Volume Market Share by Top Companies (2012-2017)
    Figure United States Dermatology Drug Sales Volume Market Share by Top Companies 2016
    Figure United States Dermatology Drug Sales Volume Market Share by Top Companies 2017
    Table United States Dermatology Drug Revenue (Million USD) by Top Companies (2012-2017)
    Table United States Dermatology Drug Revenue Market Share by Top Companies (2012-2017)
    Figure United States Dermatology Drug Revenue Market Share by Top Companies 2016
    Figure United States Dermatology Drug Revenue Market Share by Top Companies 2017
    Table United States Top Companies Key Product Model and Market Performance
    Table United States Top Companies Key Target Consumers and Market Performance
    Table Global Dermatology Drug Sales (K MT) by Consumer (2012-2017)
    Figure Global Dermatology Drug Sales Market Share by Consumer (2012-2017)
    Figure Global Dermatology Drug Sales Market Share by Consumer in 2016
    Figure Global Psoriasis Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Figure Global Skin Infections Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Figure Global Acne Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Figure Global Dermatitis Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Figure Global Other Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table United States Dermatology Drug Sales (K MT) by Consumer (2012-2017)
    Figure United States Dermatology Drug Sales Market Share by Consumer (2012-2017)
    Figure United States Dermatology Drug Sales Market Share by Consumer in 2016
    Figure United States Psoriasis Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Figure United States Skin Infections Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Figure United States Acne Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Figure United States Dermatitis Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Figure United States Other Dermatology Drug Sales (K MT) and Growth Rate (2012-2017)
    Table AbbVie (U.S.) Company Details and Competitors
    Table AbbVie (U.S.) Key Dermatology Drug Models and Performance
    Table AbbVie (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
    Table AbbVie (U.S.) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure AbbVie (U.S.) Dermatology Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure AbbVie (U.S.) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure AbbVie (U.S.) Dermatology Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure AbbVie (U.S.) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Johnson & Johnson (U.S.) Company Details and Competitors
    Table Johnson & Johnson (U.S.) Key Dermatology Drug Models and Performance
    Table Johnson & Johnson (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
    Table Johnson & Johnson (U.S.) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Dermatology Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Johnson & Johnson (U.S.) Dermatology Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Bayer (Germany) Company Details and Competitors
    Table Bayer (Germany) Key Dermatology Drug Models and Performance
    Table Bayer (Germany) Dermatology Drug Business SWOT Analysis and Forecast
    Table Bayer (Germany) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Bayer (Germany) Dermatology Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Bayer (Germany) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Bayer (Germany) Dermatology Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Bayer (Germany) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Galderma (Switzerland) Company Details and Competitors
    Table Galderma (Switzerland) Key Dermatology Drug Models and Performance
    Table Galderma (Switzerland) Dermatology Drug Business SWOT Analysis and Forecast
    Table Galderma (Switzerland) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Galderma (Switzerland) Dermatology Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Galderma (Switzerland) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Galderma (Switzerland) Dermatology Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Galderma (Switzerland) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Bristol-Myers Squibb (U.S.) Company Details and Competitors
    Table Bristol-Myers Squibb (U.S.) Key Dermatology Drug Models and Performance
    Table Bristol-Myers Squibb (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
    Table Bristol-Myers Squibb (U.S.) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Novartis (China) Company Details and Competitors
    Table Novartis (China) Key Dermatology Drug Models and Performance
    Table Novartis (China) Dermatology Drug Business SWOT Analysis and Forecast
    Table Novartis (China) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Novartis (China) Dermatology Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Novartis (China) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Novartis (China) Dermatology Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Novartis (China) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Pfizer (U.S.) Company Details and Competitors
    Table Pfizer (U.S.) Key Dermatology Drug Models and Performance
    Table Pfizer (U.S.) Dermatology Drug Business SWOT Analysis and Forecast
    Table Pfizer (U.S.) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Pfizer (U.S.) Dermatology Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Pfizer (U.S.) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Pfizer (U.S.) Dermatology Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Pfizer (U.S.) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Merz Pharma (Germany) Company Details and Competitors
    Table Merz Pharma (Germany) Key Dermatology Drug Models and Performance
    Table Merz Pharma (Germany) Dermatology Drug Business SWOT Analysis and Forecast
    Table Merz Pharma (Germany) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Merz Pharma (Germany) Dermatology Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Merz Pharma (Germany) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Merz Pharma (Germany) Dermatology Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Merz Pharma (Germany) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table Valeant (Canada) Company Details and Competitors
    Table Valeant (Canada) Key Dermatology Drug Models and Performance
    Table Valeant (Canada) Dermatology Drug Business SWOT Analysis and Forecast
    Table Valeant (Canada) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Valeant (Canada) Dermatology Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Valeant (Canada) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure Valeant (Canada) Dermatology Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Valeant (Canada) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table LEO Pharma (Denmark) Company Details and Competitors
    Table LEO Pharma (Denmark) Key Dermatology Drug Models and Performance
    Table LEO Pharma (Denmark) Dermatology Drug Business SWOT Analysis and Forecast
    Table LEO Pharma (Denmark) Dermatology Drug Output (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure LEO Pharma (Denmark) Dermatology Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure LEO Pharma (Denmark) Dermatology Drug Sales Market Share (%) in Global (2012-2017)
    Figure LEO Pharma (Denmark) Dermatology Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure LEO Pharma (Denmark) Dermatology Drug Revenue Market Share (%) in Global (2012-2017)
    Table GlaxoSmithKline (UK) Company Details and Competitors
    Figure Global Dermatology Drug Sales (K MT) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Dermatology Drug Price (USD/MT) Trend Forecast (2017-2022)
    Table Global Dermatology Drug Sales (K MT) Forecast by Regions (2017-2022)
    Table Global Dermatology Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Dermatology Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Dermatology Drug Sales Volume Share Forecast by Regions in 2022
    Table Global Dermatology Drug Sales (K MT) Forecast by Application (2017-2022)
    Figure Global Dermatology Drug Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Dermatology Drug Sales Volume Market Share Forecast by Application in 2022
    Table Global Dermatology Drug Sales (K MT) Forecast by Route of Administration (2017-2022)
    Figure Global Dermatology Drug Sales (K MT) Forecast by Route of Administration (2017-2022)
    Figure Global Dermatology Drug Sales Volume Market Share Forecast by Route of Administration in 2022
    Table Global Dermatology Drug Sales (K MT) Forecast by Form (2017-2022)
    Figure Global Dermatology Drug Sales (K MT) Forecast by Form (2017-2022)
    Figure Global Dermatology Drug Sales Volume Market Share Forecast by Form in 2022
    Figure United States Dermatology Drug Sales (K MT) and Growth Rate (%) Forecast (2017-2022)
    Figure United States Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Dermatology Drug Price (USD/MT) Trend Forecast (2017-2022)
    Table United States Dermatology Drug Sales (K MT) Forecast by Regions (2017-2022)
    Table United States Dermatology Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Dermatology Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Dermatology Drug Sales Volume Share Forecast by Regions in 2022
    Table United States Dermatology Drug Sales (K MT) Forecast by Application (2017-2022)
    Figure United States Dermatology Drug Sales Volume Market Share Forecast by Application (2017-2022)
    Figure United States Dermatology Drug Sales Volume Market Share Forecast by Application in 2022
    Table United States Dermatology Drug Sales (K MT) Forecast by Route of Administration (2017-2022)
    Figure United States Dermatology Drug Sales (K MT) Forecast by Route of Administration (2017-2022)
    Figure United States Dermatology Drug Sales Volume Market Share Forecast by Route of Administration in 2022
    Table United States Dermatology Drug Sales (K MT) Forecast by Form (2017-2022)
    Figure United States Dermatology Drug Sales (K MT) Forecast by Form (2017-2022)
    Figure United States Dermatology Drug Sales Volume Market Share Forecast by Form in 2022